[go: up one dir, main page]

GB201803387D0 - Disease detection - Google Patents

Disease detection

Info

Publication number
GB201803387D0
GB201803387D0 GBGB1803387.8A GB201803387A GB201803387D0 GB 201803387 D0 GB201803387 D0 GB 201803387D0 GB 201803387 A GB201803387 A GB 201803387A GB 201803387 D0 GB201803387 D0 GB 201803387D0
Authority
GB
United Kingdom
Prior art keywords
disease detection
disease
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1803387.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One Health Ventures Ltd
Original Assignee
One Health Ventures Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Health Ventures Ltd filed Critical One Health Ventures Ltd
Priority to GBGB1803387.8A priority Critical patent/GB201803387D0/en
Publication of GB201803387D0 publication Critical patent/GB201803387D0/en
Priority to PCT/GB2019/050590 priority patent/WO2019166832A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
GBGB1803387.8A 2018-03-02 2018-03-02 Disease detection Ceased GB201803387D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1803387.8A GB201803387D0 (en) 2018-03-02 2018-03-02 Disease detection
PCT/GB2019/050590 WO2019166832A1 (en) 2018-03-02 2019-03-01 Disease detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1803387.8A GB201803387D0 (en) 2018-03-02 2018-03-02 Disease detection

Publications (1)

Publication Number Publication Date
GB201803387D0 true GB201803387D0 (en) 2018-04-18

Family

ID=61903714

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1803387.8A Ceased GB201803387D0 (en) 2018-03-02 2018-03-02 Disease detection

Country Status (2)

Country Link
GB (1) GB201803387D0 (en)
WO (1) WO2019166832A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230080397A (en) * 2020-08-07 2023-06-07 오타이르 프로테나 리미티드 Multi-epitope vaccine to treat Alzheimer's disease
WO2024173889A1 (en) * 2023-02-17 2024-08-22 Cornell University Etx dependent diagnosis and therapy of multiple sclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014216127B2 (en) * 2013-02-14 2018-07-12 Cornell University Methods to protect against and treat multiple sclerosis

Also Published As

Publication number Publication date
WO2019166832A1 (en) 2019-09-06

Similar Documents

Publication Publication Date Title
GB201917181D0 (en) No details
GB201917180D0 (en) No details
GB201917178D0 (en) No details
GB2572126B (en) Pharmaceutical
GB2569961B (en) Pharmaceutical
GB201910775D0 (en) No Details
GB2572125B (en) Pharmaceutical
GB202018989D0 (en) Malware detection
SG11202102280SA (en) Retrographic sensors
SG10201912481VA (en) Coherence change detection techniques
GB201821331D0 (en) Inhaler detection
GB2591432B (en) Animal detection
GB201712357D0 (en) Spetral imaging
SG11202113179WA (en) Context detection
GB201908106D0 (en) No details
EP3749833C0 (en) Downhole detection
GB2570742B (en) Optical-interference analysis
GB201701480D0 (en) Disease resistance
GB201803387D0 (en) Disease detection
GB201905867D0 (en) No details
GB201909661D0 (en) Early entry
GB201804172D0 (en) Improved capnometer
IL283273A (en) Pharmaceutical methods
GB2576666B (en) Sequence detection
GB201816607D0 (en) Light-sheet imaging

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)